Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: the MALACHITE-I/II trials

Absztrakt
Leírás
Kulcsszavak
Forrás
Journal Of Hepatology. -64 : 1 (2016), p. 19-28. -J. Hepatol. - 0168-8278